CK-MB、BNP及纤维蛋白原/白蛋白比值对老年慢性心力衰竭病人再入院率的预测价值

doi:10.3969/j.issn.1003-9198.2023.02.015

摘要/Abstract

摘要： 目的探讨肌酸激酶同工酶(CK-MB)、BNP及纤维蛋白原/白蛋白比值(FAR)对老年CHF病人再入院率的预测价值。方法收集2018年3月至2020年10月本院收治的CHF病人132例,其中NYHA心功能分级Ⅱ级55例、Ⅲ级41例、Ⅳ级36例。所有病人随访1年,根据是否再次入院分为再次入院组(45例)和未再次入院组(87例)。比较2组血清CRP、降钙素原(PCT)、BNP、CK-MB、FAR水平。采用ROC曲线分析CRP、PCT、CK-MB、BNP、FAR对CHF病人再次入院的预测价值。结果心功能Ⅱ、Ⅲ、Ⅳ级病人CRP、PCT、BNP、CK-MB水平及FAR依次显著升高,不同心功能级别间比较差异均有统计学意义(P＜0.05)。与未再次入院组相比,再次入院组病人CRP、PCT、BNP、CK-MB及FAR水平较高(P＜0.05)。ROC曲线显示,CRP、PCT、BNP、CK-MB、FAR预测CHF病人再次入院的AUC分别为0.790、0.785、0.804、0.841、0.869,BNP、CK-MB、FAR三者联合预测CHF病人再次入院的AUC为0.884,灵敏度、特异度分别为82.20%、88.50%。结论血清CK-MB、BNP、FAR在CHF再次入院病人中呈高水平,三者联合检测对CHF病人再次入院具有一定的临床预测价值。

关键词: 老年人, 慢性心力衰竭, 肌酸激酶同工酶, B型钠尿肽, 纤维蛋白原/白蛋白比值

Abstract: Objective To investigate the predictive value of creatine kinase isoenzyme (CK-MB), B-type natriuretic peptide (BNP) and fibrinogen to albumin ratio (FAR) on readmission rate in the elderly patients with chronic heart failure (CHF). Methods A total of 132 CHF patients admitted to our hospital from March 2018 to October 2020 were enrolled. According to the New York Heart Association (NYHA)cardiac function classification, there were 55 cases of grade Ⅱ, 41 cases of grade Ⅲ and 36 cases of grade Ⅳ. All the patients were followed up for 1 year and were divided into the readmission group (45 cases) and the non-readmission group (87 cases) according to whether they were readmitted. The serum levels of C-reactive protein (CRP), procalcitonin (PCT), BNP, CK-MB and FAR in the two groups were detected and compared. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of CRP, PCT, CK-MB, BNP, and FAR for readmission in the elderly patients with CHF. Results The levels of CRP, PCT, BNP, CK-MB and FAR in grade Ⅱ, grade Ⅲ and grade Ⅳ group were significantly increased in turn (P<0.05).Compared with the non-readmission group, the levels of CRP, PCT, BNP, CK-MB and FAR were significantly higher in the readmission group (P<0.05).The ROC curve showed that the area under the curve (AUC) of CRP, PCT, BNP, CK-MB, and FAR for predicting readmission of CHF patients was 0.790, 0.785, 0.804, 0.841, and 0.869, respectively. The AUC of the combination of BNP,CK-MB and FAR to predict the readmission of CHF patients was 0.884, and the sensitivity and specificity was 82.20% and 88.50%, respectively. Conclusions The serum levels of CK-MB, BNP, and FAR are high in CHF readmission patients, and the combination detection of the three indexes shows significant clinical value in predicting CHF readmission.

Key words: aged, chronic heart failure, creatine kinase isoenzyme, B-type natriuretic peptide, fibrinogen to albumin ratio

中图分类号:

R 541.6

程忠良, 凌燕, 梁晓辉. CK-MB、BNP及纤维蛋白原/白蛋白比值对老年慢性心力衰竭病人再入院率的预测价值[J]. 实用老年医学, 2023, 37(2): 168-172.

CHENG Zhong-liang, LING Yan, LIANG Xiao-hui. Predictive value of CK-MB, BNP and fibrinogen to albumin ratio on readmission rate in elderly patients with chronic heart failure[J]. Practical Geriatrics, 2023, 37(2): 168-172.

参考文献

[1] 朱国超. 血清B型尿钠肽和肽素水平对老年慢性心力衰竭患者预后不良的预测价值[J].中国老年学杂志, 2019, 39(19):4646-4650.
[2] GREENE S J, BUTLER J, SPERTUS J A, et al. Comparison of new york heart association class and patient-reported outcomes for heart failure with reduced ejection fraction[J]. JAMA Cardiol, 2021, 6(5):522-531.
[3] 唐琦, 周依群, 廖坚, 等. 护理主导的多学科健康教育对CHF患者照护结局的影响[J]. 上海护理, 2018, 18(9):58-61.
[4] 朱秀英, 吴畏, 李广鹏, 等. 血清PCT、D-二聚体及BNP在急性心肌梗死患者PCI后心功能及预后的应用价值[J]. 中国循证心血管医学杂志, 2020, 12(4):455-459,463.
[5] 许抗抗, 杨国爱, 陈晓琳, 等. NLR、MPV、脑钠肽评估心力衰竭病人预后的临床价值及其相关性分析[J]. 中西医结合心脑血管病杂志, 2021, 19(17):2970-2973.
[6] 储莉, 刘伏元, 闻伟, 等. CK-MB、cTnI联合Fib对老年慢性心力衰竭患者诊断和预后的价值[J]. 中国老年学杂志, 2021, 41(14):2927-2931.
[7] 熊国均, 黄楷森, 欧荣华, 等. 纤维蛋白原与白蛋白比值对多支血管病变性急性心肌梗死患者PCI术后远期预后的预测价值[J]. 疑难病杂志, 2019, 18(12):1212-1217.
[8] PONIKOWSKI P, VOORS A A, ANKER S D, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur J Heart Fail, 2016, 18(8):891-975.
[9] 中华医学会心血管病学分会. 中华心血管病杂志编辑委员会·中国心力衰竭诊断和治疗指南2014[J]. 中华心血管病杂志, 2014, 42(2):98-122.
[10] 陈炜. 急性心力衰竭的诊断和治疗指南解读:2012年更新版ESC 急慢性心力衰竭诊断和治疗[J]. 中华危重病急救医学, 2013, 25(11):698-702.
[11] 刘黎霞, 柳森, 谢东君, 等. 慢性心力衰竭预后生物标志物预测模型的建立[J]. 中国临床实用医学, 2021, 12(6):52-56.
[12] 任芳, 王一丹, 甘丰. 血清hs-CRP、sICAM-1在慢性心力衰竭患者中的变化及与近期预后的相关性[J]. 中国实验诊断学, 2021, 25(8):1107-1111.
[13] 张艳超, 翟玉民. 血清胱抑素C及糖类抗原125对老慢性心力衰竭患者预后的评估[J]. 中华老年心脑血管病杂志, 2019, 21(2):137-140.
[14] 徐立彦, 李晨, 王华, 等. 慢性心力衰竭合并肺部感染患者心肌酶谱4项及炎症因子水平变化[J]. 贵阳医学院学报, 2020, 45(5):611-615.
[15] LING S, XU J W. NETosis as a pathogenic factor for heart failure[J]. Oxid Med Cell Longev, 2021, 2021(1):1-24.
[16] 弥娜, 王玉静, 叶丽辉, 等. 超声心动图与血浆BNP、和肽素、hs-CRP对慢性心力衰竭患者心功能的评估价值分析[J]. 现代生物医学进展, 2020, 20(9):1703-1706.
[17] 郑少燕, 张志英, 朱丹萍, 等. 糖类抗原125、B型钠尿肽评价慢性心力衰竭患者心功能的价值[J]. 医学信息, 2021, 34(19):104-106.
[18] 梁吉斌, 徐宏勇. 血清PCT、D二聚体及BNP在急性心肌梗死患者PCI后心功能及预后的临床价值[J]. 血栓与止血学, 2022, 28(1):59-61.
[19] 许鹏, 陈敏. 不同NYHA心功能分级慢性心力衰竭患者心脏标志物四项、PCT、BNP水平变化及临床意义[J]. 海南医学, 2021, 32(19):2488-2491.
[20] 赵大林, 王建, 谢陈玲. 慢性心力衰竭患者血清CK-MB,cTnT与病情严重程度及临床预后的关系[J]. 临床与病理杂志, 2020, 40(6):1363-1368.
[21] 王同, 王丰云, 张倩倩, 等. 纤维蛋白原/白蛋白比值预测冠状动脉慢性完全闭塞病变侧支循环形成及预后的价值[J]. 中华全科医学, 2021, 19(10):1637-1641.
[22] 苏建培, 田伟盟, 顾俊, 等. C反应蛋白/白蛋白比值与老年心力衰竭患者长期预后的关系[J]. 昆明医科大学学报, 2020, 41(12):128-132.
[23] 石磊, 李万鹏, 安军钰, 等. 纤维蛋白原与白蛋白比值对NSTE-ACS患者院内发生主要心脏不良事件的预测价值[J]. 河北医科大学学报, 2021, 42(3):262-267.